Literature DB >> 10551290

Efficacy of supratarsal dexamethasone versus triamcinolone injection in recalcitrant vernal keratoconjunctivitis.

J S Saini1, A Gupta, S K Pandey, V Gupta, P Gupta.   

Abstract

PURPOSE: To compare the efficacy of supratarsal injection of short acting dexamethasone sodium phosphate versus intermediate acting triamcinolone acetonide as a new therapeutic modality for treating eyes with recalcitrant vernal keratoconjunctivitis (VKC).
METHODS: The study was a prospective, randomized, double blind, case controlled trial, including 38 eyes of 19 patients with recalcitrant VKC. Except for two initial patients who received supratarsal injection of triamcinolone acetonide in both the eyes, one eye of each patient was randomly assigned to receive either 2 mg of dexamethasone sodium phosphate or 20 mg of triamcinolone acetonide.
RESULTS: Both the drugs were equally effective with no statistically significant difference in the mean time of resolution of cobblestone papillae, limbal edema, shield ulcer, SPK and relief of symptoms. The recurrence rate of disease was, however, lower following triamcinolone acetonide injection.
CONCLUSIONS: Supratarsal injection of corticosteroid is a cheap, effective and safe modality of treatment for managing eyes with recalcitrant VKC. Both short acting dexamethasone and intermediate acting triamcinolone acetonide are equally effective.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10551290     DOI: 10.1034/j.1600-0420.1999.770505.x

Source DB:  PubMed          Journal:  Acta Ophthalmol Scand        ISSN: 1395-3907


  8 in total

1.  Vernal keratoconjunctivitis.

Authors:  Anthony Hall; Bernadetha Shilio
Journal:  Community Eye Health       Date:  2005-03

2.  Dermatologic tacrolimus ointment on the eyelids for steroid-refractory vernal keratoconjunctivitis.

Authors:  Fang-Yu Liu; Hsin-Yu Liu; Hsiao-Sang Chu; Wei-Li Chen; Fung-Rong Hu; I-Jong Wang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-03-09       Impact factor: 3.117

3.  Modern approach to managing vernal keratoconjunctivitis.

Authors:  Sunil Kumar; Nitin Gupta; Anthony J Vivian
Journal:  Curr Allergy Asthma Rep       Date:  2010-05       Impact factor: 4.806

4.  Supratarsal injection of triamcinolone acetonide and childhood allergic keratoconjunctivitis.

Authors:  Sonia Zaouali; Rim Kahloun; Sonia Attia; Bechir Jelliti; Manel Trigui; Salim Ben Yahia; Riadh Messaoud; Moncef Khairallah
Journal:  Int Ophthalmol       Date:  2012-02-14       Impact factor: 2.031

5.  [Vernal keratoconjunctivitis].

Authors:  U Pleyer; A Leonardi
Journal:  Ophthalmologe       Date:  2015-02       Impact factor: 1.059

6.  Treatment of asymmetrical vernal keratoconjunctivitis with supratarsal corticosteroid injection.

Authors:  Onsiri Thanathanee; Chavakij Bhoomibunchoo; Olan Suwan-apichon
Journal:  BMJ Case Rep       Date:  2014-11-19

Review 7.  [Therapeutic options in vernal keratoconjunctivitis].

Authors:  E M Messmer
Journal:  Ophthalmologe       Date:  2009-06       Impact factor: 1.059

Review 8.  Local delivery of corticosteroids in clinical ophthalmology: A review.

Authors:  Adrian T Fung; Tuan Tran; Lyndell L Lim; Chameen Samarawickrama; Jennifer Arnold; Mark Gillies; Caroline Catt; Logan Mitchell; Andrew Symons; Robert Buttery; Lisa Cottee; Krishna Tumuluri; Paul Beaumont
Journal:  Clin Exp Ophthalmol       Date:  2020-01-22       Impact factor: 4.207

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.